DocGo Inc (DCGO)vsDaVita HealthCare Partners Inc (DVA)
DCGO
DocGo Inc
$0.23
-2.98%
HEALTHCARE · Cap: $24.44M
DVA
DaVita HealthCare Partners Inc
$174.07
-5.14%
HEALTHCARE · Cap: $11.67B
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 4707% more annual revenue ($14.17B vs $294.72M). DVA leads profitability with a 6.5% profit margin vs -65.3%. DVA earns a higher WallStSmart Score of 70/100 (B-).
DCGO
Hold36
out of 100
Grade: F
DVA
Strong Buy70
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+62.1%
Fair Value
$1.92
Current Price
$0.23
$1.69 discount
Margin of Safety
-9.6%
Fair Value
$131.65
Current Price
$174.07
$42.42 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Growing faster than its price suggests
Every $100 of equity generates 81 in profit
Earnings expanding 66.7% YoY
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -141.9% — below average capital efficiency
Revenue declined 8.7%
4.6% revenue growth
6.5% margin — thin
Weak financial health signals
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : DCGO
The strongest argument for DCGO centers on Price/Book, Debt/Equity.
Bull Case : DVA
The strongest argument for DVA centers on PEG Ratio, Return on Equity, EPS Growth. PEG of 0.47 suggests the stock is reasonably priced for its growth.
Bear Case : DCGO
The primary concerns for DCGO are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : DVA
The primary concerns for DVA are Revenue Growth, Profit Margin, Piotroski F-Score.
Key Dynamics to Monitor
DCGO profiles as a turnaround stock while DVA is a value play — different risk/reward profiles.
DCGO carries more volatility with a beta of 0.97 — expect wider price swings.
DVA is growing revenue faster at 4.6% — sustainability is the question.
DVA generates stronger free cash flow (359M), providing more financial flexibility.
Bottom Line
DVA scores higher overall (70/100 vs 36/100). DCGO offers better value entry with a 62.1% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DocGo Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DocGo Inc. is a leading mobile healthcare service provider focused on enhancing patient accessibility and optimizing healthcare delivery through its cutting-edge logistics and telehealth solutions. The company specializes in urgent care, diagnostic testing, and health screenings, effectively addressing key healthcare challenges across diverse environments and significantly improving patient experiences. With a strong commitment to innovation and expanding access to healthcare, DocGo is well-positioned in the dynamic healthtech sector, making it an attractive investment opportunity for institutional investors interested in sustainable growth and impactful social contributions.
Visit Website →DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?